Overview

Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia

Status:
Terminated

Trial end date:
2015-12-30

Target enrollment:

Participant gender:

Summary

Feasibility and toxicity of haploidentical allogeneic HCT after a reduced intensity conditioning regimen with CD3/CD19 depleted grafts. This study enrolls patients with acute leukemia in complete remission with an indication for allogeneic HCT but without a suitable HLA-identical donor

Phase:

Phase 2

Details

Lead Sponsor:

University Hospital Tuebingen

Treatments:

Fludarabine
Fludarabine phosphate
Melphalan
Thiotepa
Thymoglobulin